A Randomized, Open-label, LOSARTAN Therapy on the Progression of Aortic Root Dilation in Patients With Marfan Syndrome

NCT00651235 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

44

Enrollment

OTHER

Sponsor class

Conditions

Marfan Syndrome

Interventions

DRUG: Losartan and Atenolol or Propranolol
DRUG: Atenolol or Propranolol

Sponsor

National Taiwan University Hospital